FDA Warning Letter — Rubix

Case 547155 — FEI 3014231143

The FDA took a Warning Letter action against Rubix on Feb 22, 2018 (Cincinnati, OH). The action was issued by CTP and concerns tobacco products.

Action Details

Facility
Rubix
Date
Feb 22, 2018
Fiscal Year
2018
Product Type
Tobacco
Center
CTP
Location
Cincinnati, OH (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.